Background: The aim of this study was to identify more accurate variables to improve prognostication of individual patients with colorectal liver metastases (CRLM). Clinicopathological characteristics only partly explain the large range in survival rates. Methods: MessengerRNA expression profiles of resected CRLM of two patient groups were analysed by mRNA sequencing: poor survivors (death from recurrent disease 60 months after surgery). Tumour and adjacent liver parenchyma samples were analysed. Results: MessengerRNA expression profiling of the tumour samples identified 77 genes that were differentially expressed between the two survival groups at a False Discovery Rate (FDR) <0.1. In the adjacent liver parenchyma samples only one...
Abstract BACKGROUND: Several prognostic factors were proposed to improve early detection of r...
Background and Objectives: This study was designed to identify and validate gene signatures that can...
Background/Aim: To assess the expression of cancer stem cell (CSC) markers CD44, CD133 and CD24 in c...
Background: The aim of this study was to identify more accurate variables to improve prognostication...
Background: The current prognostication of patient survival after surgery for colorectal liver metas...
textabstractBackground: Identification of specific risk groups for recurrence after surgery for isol...
BACKGROUND: Although surgery is the gold standard treatment of hepatic metastasis from colorectal c...
Though immune responses correlate with prognosis in primary colorectal cancer, the role of tumor imm...
Background: Many studies have investigated the prognostic role of biomarkers in colorectal liver met...
Despite improvements in the multi-modality treatment of colorectal liver metastasis (CRLM), survival...
Purpose: The aim of this study was to build a molecular prognostic model based on gene signatures fo...
Aim: Colorectal cancer infiltrating cytotoxic T-cells (CD8+ cells) are a strong prognostic factor fo...
PURPOSE: The aim of this study was to build a molecular prognostic model based on gene signatures fo...
Colorectal cancer (CRC) accounts for one in ten cancer deaths worldwide, most commonly secondary to ...
Abstract BACKGROUND: Several prognostic factors were proposed to improve early detection of r...
Background and Objectives: This study was designed to identify and validate gene signatures that can...
Background/Aim: To assess the expression of cancer stem cell (CSC) markers CD44, CD133 and CD24 in c...
Background: The aim of this study was to identify more accurate variables to improve prognostication...
Background: The current prognostication of patient survival after surgery for colorectal liver metas...
textabstractBackground: Identification of specific risk groups for recurrence after surgery for isol...
BACKGROUND: Although surgery is the gold standard treatment of hepatic metastasis from colorectal c...
Though immune responses correlate with prognosis in primary colorectal cancer, the role of tumor imm...
Background: Many studies have investigated the prognostic role of biomarkers in colorectal liver met...
Despite improvements in the multi-modality treatment of colorectal liver metastasis (CRLM), survival...
Purpose: The aim of this study was to build a molecular prognostic model based on gene signatures fo...
Aim: Colorectal cancer infiltrating cytotoxic T-cells (CD8+ cells) are a strong prognostic factor fo...
PURPOSE: The aim of this study was to build a molecular prognostic model based on gene signatures fo...
Colorectal cancer (CRC) accounts for one in ten cancer deaths worldwide, most commonly secondary to ...
Abstract BACKGROUND: Several prognostic factors were proposed to improve early detection of r...
Background and Objectives: This study was designed to identify and validate gene signatures that can...
Background/Aim: To assess the expression of cancer stem cell (CSC) markers CD44, CD133 and CD24 in c...